{"hq_id":"hq-p-pet-000067","name":"Seresto Flea and Tick Collar for Dogs and Cats (Imidacloprid/Flumethrin, EPA Safety Review, 8-Month Sustained Release)","category":{"primary":"pet_care","secondary":"flea_tick_collar","tags":["Seresto","imidacloprid","flumethrin","flea collar","tick collar","dog","cat","neonicotinoid","sustained release","EPA review"]},"product_tier":"PET","overall_risk_level":"moderate","description":"Seresto collars combine the neonicotinoid imidacloprid (10%) with the pyrethroid flumethrin (4.5%) in a polymer matrix that provides 8-month sustained release for flea and tick prevention on dogs and cats. Seresto became the best-selling flea/tick collar worldwide with over 25 million units sold annually, but faced scrutiny after a 2021 USA Today investigation reported over 2,500 pet deaths and 75,000+ adverse incident reports linked to the product in the EPA Incident Data System. EPA conducted an enhanced review (2021-2023) and concluded the overall safety profile was acceptable given the large user population, though neurological adverse events (ataxia, tremors) occurred at rates above background. Imidacloprid acts on nicotinic acetylcholine receptors in arthropods; flumethrin is a Type II pyrethroid affecting sodium channels.","synthesis":{"derived_risk_level":"moderate","synthesis_confidence":0.82,"synthesis_method":"compound_composition","context_used":"human_adult","context_source":"product_users","exposure_modifier":1,"vulnerability_escalated":true,"escalation_reason":"Child exposure group","compounds_resolved":2,"compounds_total":2,"synthesis_date":"2026-03-27","synthesis_version":"1.0.0"},"hazard_summary":{"sensitive_populations":"puppies and kittens under 7 weeks, small breed dogs, elderly pets, children who mouth/chew collar","overall_risk":"moderate","primary_concerns":["75,000+ adverse incident reports in EPA database including 2,500+ pet deaths","Neurological adverse events (ataxia, seizures, tremors) at rates above background","8-month continuous chemical exposure with no user-adjustable dosing","Child exposure risk from mouthing collar or prolonged skin contact during cuddling"],"exposure_routes":"Dermal (continuous from collar polymer matrix). Ingestion (collar chewing by pets or children). Transfer (contact between pets)."},"exposure":{"routes":["dermal","ingestion"],"contact_types":["dermal_prolonged","ingestion_accidental"],"users":["pet_dog","pet_cat","child","adult"],"duration":"chronic","frequency":"continuous_8_months","scenarios":["Pet: continuous low-dose dermal exposure over 8-month collar life","Child: dermal contact when petting; toddler mouthing/chewing collar","Pet ingestion: collar chewing releases concentrated active ingredients","Multi-pet household: contact transfer between collar-wearing and non-collar pets"],"notes":"Seresto: patented slow-release polymer matrix. 25+ million units/year global sales. USA Today investigation (2021): 2,500+ pet deaths, 75,000+ adverse incidents in EPA database over 9 years. EPA enhanced review (2021-2023): concluded benefit-risk profile acceptable. Adverse events include ataxia, seizures, lethargy, skin irritation. Neurological events: 12.4 per million collars sold (EPA analysis). Imidacloprid mammalian toxicity relatively low (dog oral LD50 >450 mg/kg) compared to arthropod selectivity."},"consumer_guidance":{"usage_warning":"Monitor your pet for signs of adverse reaction (scratching at collar site, lethargy, tremors, loss of coordination) especially in the first week. Remove collar immediately if adverse signs appear. Keep collar packaging and extra length trimmed away from children. Report adverse events to EPA (npic.orst.edu) and your veterinarian. Consider the large user population context: 12.4 adverse neurological events per million collars sold.","safer_alternatives":["Monthly oral isoxazoline preventives (prescription, veterinarian-supervised dosing)","Monthly topical spot-on treatments (shorter exposure window)","Seresto in combination with regular veterinary monitoring","Non-chemical approaches (flea combs, environmental management) as supplements"]},"regulatory":{"applicable_regulations":[{"jurisdiction":"USA","regulation":"EPA Enhanced Review of Seresto Collar (2021-2023)","citation":"EPA-HQ-OPP-2021-0291; FIFRA Section 6(a)(2) adverse effects reporting","requirements":"EPA conducted enhanced safety review following media reports of adverse incidents. Concluded overall safety profile acceptable. Elanco required to submit additional post-market surveillance data. Enhanced adverse event reporting requirements. Label must include adverse reaction guidance.","compliance_status":null,"effective_date":"2023-01-01","enforcing_agency":"EPA Office of Pesticide Programs","penalties":null,"source_ref":null}],"certifications":[],"labeling":{"required_disclosures":[],"prop65_warning":{"required":null,"chemicals":[],"endpoint":null,"notes":null},"ghs_labeling":{"required":null,"signal_word":null,"pictograms":[],"hazard_statements":[],"notes":null},"hidden_ingredients":{"trade_secret_protected":null,"categories_hidden":[],"estimated_count":null,"known_concerns":null,"notes":null},"notes":null},"recalls":[],"regulatory_gap":null,"notes":null},"lifecycle":{"recyclable":false,"disposal_guidance":"Remove collar from pet after 8 months. Wrap in newspaper and dispose in household trash. Do not incinerate or compost.","hazardous_waste":false,"expected_lifespan":"8-month active life per collar"},"formulation":{"form":"varies","key_ingredients":[],"certifications":[]},"materials":{"common":[],"concerning":[],"preferred":[]},"compound_composition":[{"hq_id":"hq-c-org-000065","compound_name":null,"role":"active_ingredient","typical_concentration":"10% imidacloprid in polymer matrix; neonicotinoid acting on insect nicotinic acetylcholine receptors"},{"hq_id":"hq-c-org-000024","compound_name":null,"role":"synergist_class","typical_concentration":"4.5% flumethrin (Type II pyrethroid); synergizes with imidacloprid for tick repellency and kill"}],"identifiers":{"common_names":["seresto flea and tick collar for dogs and cats (imidacloprid/flumethrin, epa safety review, 8-month sustained release)"],"aliases":[],"manufacturer":null,"brands":[]},"brand_examples":[],"sources":[{"type":"expert_curation","name":"ALETHEIA Safety Database","date":"2026-03-26"}],"meta":{"schema_version":"4.0.0","last_updated":"2026-03-26","timestamp":"2026-05-02T18:29:45.816Z"}}